5 steps to help increase the odds of clinical trial success
BioPharma Dive,
Sponsored content Pharmaceutical companies can spend 10 to 15 years and more than $2.3 billion to bring new drugs to market.
Addex Ends Trials Evaluating Parkinson's Treatment Due to Slow Recruitment
Biospace,
Switzerland-based Addex Therapeutics announced it is canceling its Phase IIb/III study evaluating its drug dipraglurant as a…
Clinical Trial Upgrades Will Open Care Up to More People
Medscape,
Trishna Bharadia has multiple sclerosis and works as a patient engagement consultant and is often asked to participate in…
Clinical Trial Upgrades Will Open Care Up to More People - swifttelecast
Swift Telecast,
May 26, 2022 – Trishna Bharadia has multiple sclerosis and works as a patient engagement consultant and is often asked to take…